Add BrightSurf on Google Email

Point-of-care hepatitis C testing in a tribal setting

A community-based point-of-care HCV RNA testing program was feasible and led to a high percentage of same-day treatment for American Indian and Alaska Native participants. The study supports expanding point-of-care HCV RNA testing and integrated treatment to advance HCV elimination.

SourceJAMA Network·JournalJAMA Network Open·DateApr 15, 2026

Study finds sex- and race-based disparities in IBS diagnosis rates among US adults

A national survey found significant disparities in IBS diagnosis across sex and racial groups in the US. Men and Black patients are less likely to receive a formal diagnosis compared to women and white patients, despite similar reported healthcare-seeking behavior and symptom severity.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Gastroenterology and Hepatology·TypeData/statistical analysis·DateApr 9, 2026

Colorectal cancer risk with negative colonoscopy or nonadherence after positive fecal occult blood test screening

A decrease in colorectal cancer incidence was observed among individuals with negative screening colonoscopy results, particularly men, suggesting risk-based follow-up strategies. Nonadherence to scheduled colonoscopies increased the risk of CRC, highlighting the need for targeted interventions to improve early detection.

SourceJAMA Network·JournalJAMA Network Open·DateMar 19, 2026

Early intervention in severe fetal megacystis can increase survival rate and kidney function

Researchers found that treating severe fetal megacystis with a vesicoamniotic shunt in the first trimester can improve survival rates and kidney function. In the study, 75% of children were born alive and 68% survived their first year of life, with most showing normal or only slightly impaired kidney function.

SourceUniversity of Cologne·JournalThe Lancet Child & Adolescent Health·TypeExperimental study·DateMar 13, 2026

A comprehensive review charts how psychiatry could finally diagnose what it actually treats

Emerging research across conceptual frameworks, biomarker science, digital phenotyping, and artificial intelligence synthesizes a translational pathway toward a more biologically grounded and clinically useful approach to psychiatric diagnosis. The current system falls short due to standardized clinical language and lack of biological ...

SourceGenomic Press·JournalBrain Medicine·TypeLiterature review·DateMar 10, 2026

Study finds no evidence of persistent tick-borne infection in people who link chronic illness to ticks

Researchers studied Norwegians with reported chronic health problems linked to tick bites, finding no objective evidence of persistent infections. The study suggests that physical activity and labour force participation may be more related to symptoms than tick exposure.

SourceNorwegian University of Science and Technology·JournalBMC Infectious Diseases·TypeObservational study·DateFeb 25, 2026

A CRISPR fingerprint of pathogenic C. auris fungi

A new diagnostic platform enables rapid and accurate detection of drug-resistant C. auris pathogens using CRISPR technology, allowing for more effective treatment and prevention of hospital outbreaks. The dSHERLOCK test can detect the presence of mutations causing antimicrobial resistance in just 40 minutes.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateJan 14, 2026

Shifting pathways: Community and healthcare-associated transmission of mpox in the Democratic Republic of the Congo and Europe

Researchers describe first reported mpox transmission of clade Ib in a healthcare setting outside Africa, with Ireland's nosocomial outbreak linked to local cases. In the Democratic Republic of Congo, community transmission shifted from sexual to non-sexual routes, driven by factors like overcrowding and child malnutrition.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeObservational study·DateDec 19, 2025

A new way to diagnose deadly lung infections and save lives

A new diagnostic method using AI and genetic information can accurately identify pneumonia in critically ill patients, distinguishing between infectious and non-infectious causes. The model has been shown to reduce inappropriate antibiotic use by over 80% and could lead to faster diagnosis and improved patient outcomes.

SourceUniversity of California - San Francisco·JournalNature Communications·TypeObservational study·DateDec 16, 2025

Uncovering the dynamics of sugar–protein interactions

Researchers developed a novel magnetic biosensing technique using polydopamine-coated magnetoliposomes to monitor lectin-glycan binding. The technique provides insight into the dynamics of sugar-protein interactions and holds promise for medical diagnostics, glycoscience research, and drug discovery.

SourceInstitute of Science Tokyo·JournalACS Applied Materials & Interfaces·TypeExperimental study·DateDec 9, 2025

What your sweat can reveal about your health

A new study suggests that sweat can reveal information about a person's health, including hormone levels, medication doses, and early detection of diseases like diabetes and cancer. Wearable sensors using artificial intelligence can detect specific metabolites in sweat, providing personalized health insights.

SourceUniversity of Technology Sydney·JournalJournal of Pharmaceutical Analysis·TypeLiterature review·DateDec 1, 2025

Clogged ‘drains’ in the brain a likely early-warning sign of Alzheimer’s disease, find NTU Singapore scientists

A study by NTU Singapore researchers found that enlarged perivascular spaces, or 'clogged drains', in the brain are a likely early-warning sign of Alzheimer's disease. The condition can be visually identified on routine MRI scans, complementing existing methods to detect Alzheimer's earlier.

SourceNanyang Technological University·JournalNeurology·TypeObservational study·DateNov 18, 2025

Chinese Neurosurgical Journal study explores AI tool to predict medulloblastoma subtypes and genetic risks with high accuracy

A new study published in the Chinese Neurosurgical Journal explores an AI tool that identifies medulloblastoma subgroups based on magnetic resonance imaging scans. The model achieved impressive accuracy in predicting molecular subtypes and genetic risk factors, with 91% accuracy for TP53 mutations and 87% accuracy for chromosome 11 loss.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateNov 5, 2025